Please join us for:

The Future of Clinical Trials

Open, agile, and distributed pipelines are changing research dramatically.


JUNE 6, 2017 from 12 p.m. until 1 p.m. Central Time

Reserve your spot now:

Today’s drug development pipelines are slow, unwieldy and enormously expensive to advance. How will we change them for the better?


Featuring:

Samuel volchenboum

Samuel Volchenboum

Co-founder, Litmus Health

Director, Center for Research Informatics @ The University of Chicago

Linkedin
Samuel blackman

Samuel Blackman

SVP and Head of Clinical Development Silverback Therapeutics

Juno, Seattle Genetics, GSK, Merck

Linkedin

What We’ll Discuss

Join Drs. Volchenboum and Blackman for a deep dive into the dramatic changes technology is driving in both academic and industry drug development research.

What we know for certain is that drug development pipelines are slow, unwieldy and enormously expensive to advance.

Discovering new therapeutics and biologics is, like Hollywood, a business driven by hits. Single blockbusters are expected to cover the expense of an entire pipeline.

Today clinical trials are increasingly being developed with the assistance of digital technology in order to allow researchers to be be more agile, open, and distributed.

Share this

Who should attend?

1. Clinical Leaders

Any working leader in clinical development or operations will benefit from this fast-paced discussion of what’s new and next. We’re all under pressure to craft faster, more efficient trials.

We all want to extend peak sales as long as possible.

2. Students & Researchers

Any student researcher or informaticist pursuing an advanced degree or a carre in clinical research or drug development will sincerely appreciate Drs. Volchenboum and Blackman’s perspective on which specialities are in greatest demand.

This webinar will also help align career choices with market demand.


Please join us!

JUNE 6, 2017 from 12 p.m. until 1 p.m. Central Time

Reserve your spot now:

Share this


Made possible by:

The University of Chicago Graham School of Continuing Liberal and Professional Studies seeks to extend the university’s academic values to as wide an audience as possible.

Our students boast a breadth and depth of experience in a variety of professions and academic interests, but they all share a love of learning and an understanding of the personal and professional value of education.

Litmus is a clinical data science platform focused on health-related quality of life.

We use data collected at the point of experience from wearables, smart devices, and home sensors to guide management and to inform trial endpoints.

Continuously measuring outcomes in multiple dimensions leads to faster, more efficient pipelines.